The SMYD (SET and MYND domain) family of lysine methyltransferases (KMTs) plays pivotal roles in various cellular processes, including gene expression regulation and DNA damage response. Initially identified as genuine histone methyltransferases, specific members of this family have recently been shown to methylate non-histone proteins such as p53, VEGFR, and the retinoblastoma tumor suppressor (pRb). To gain further functional insights into this family of KMTs, we generated the protein interaction network for three different human SMYD proteins (SMYD2, SMYD3, and SMYD5). Characterization of each SMYD protein network revealed that they associate with both shared and unique sets of proteins. Among those, we found that HSP90 and several of its co-chaperones interact specifically with the tetratrico peptide repeat (TPR)-containing SMYD2 and SMYD3. Moreover, using proteomic and biochemical techniques, we provide evidence that SMYD2 methylates K209 and K615 on HSP90 nucleotide-binding and dimerization domains, respectively. In addition, we found that each methylation site displays unique reactivity in regard to the presence of HSP90 co-chaperones, pH, and demethylation by the lysine amine oxidase LSD1, suggesting that alternative mechanisms control HSP90 methylation by SMYD2. Altogether, this study highlights the ability of SMYD proteins to form unique protein complexes that may underlie their various biological functions and the SMYD2-mediated methylation of the key molecular chaperone HSP90.
Introduction
Lysine methylation by the SET-domain-containing lysine methyltransferases (KMTs) has emerged as an important regulator of protein functions (Huang and Berger, 2008) and nuclear processes (Martin and Zhang, 2005) . Initially characterized as histone KMTs (HMKTs), SET domain enzymes have recently been shown to methylate a much broader repertoire of protein substrates. For example, VEGFR1 di-methylation by SMYD3 increases its kinase activity (Kunizaki et al., 2007) . The sensitivity of ER to estrogens is increased by the mono-methylation of K302 which thereby stimulates the expression of estrogen-responsive genes (Subramanian et al., 2008) . Methylation of the elongation factor E2F1 by SET7/9 decreases its lifespan whereas methylation of both p53 and pRb by the same enzyme protects their pro-apoptotic function (Chuikov et al., 2004; Munro et al., 2010) . Conversely, methylation of different target lysine residues on pRb and p53 by SMYD2 represses their apoptotic activity (Huang et al., 2006; Saddic et al., 2010) .
Based on sequence homology, SET-domain-containing KMTs are divided into seven groups (Dillon et al., 2005) . Among these, the SMYD (SET and MYND domain) group is characterized by the insertion of a MYND zinc finger (Spadaccini et al., 2006) within the SET domain (Xiao et al., 2003) . SMYD1, SMYD2, and SMYD3 share a high degree of sequence homology and, with the exception of SMYD5, human SMYD proteins harbor at least one C-terminal tetratrico peptide repeat (TPR) domain. Both TPR and MYND domains are important protein -protein interaction domains Abu-Farha et al., 2008; Yamamoto et al., 2011) . The SMYD proteins have been found to be linked to various cancers (Hamamoto et al., 2004 (Hamamoto et al., , 2006 Wang et al., 2008; Hu et al., 2009; Komatsu et al., 2009; Zou et al., 2009) and biological processes (Gottlieb et al., 2002; Brown et al., 2006; Huang et al., 2006; Tan et al., 2006; Thompson and Travers, 2008; Li et al., 2009a) . Correlatively, the interactions of SMYD proteins with different complexes were shown to modulate their cellular localization sites, functions, and KMT activities (Gottlieb et al., 2002; Hamamoto et al., 2004; Tan et al., 2006; Abu-Farha et al., 2008; Yamamoto et al., 2011) .
HSP90 is a homodimeric, ubiquitous, and essential chaperone composed of three functional domains, namely the nucleotidebinding domain (NBD), the middle domain (MD), and the dimerization domain (DD). HSP90 is involved in a large variety of biological processes, including, but not limited to, heat-shock response, signal transduction, steroid signaling, and tumorigenesis (Taipale et al., 2010) . These roles are finely regulated through the binding of co-chaperones and client proteins as well as post-translational modifications (PTMs), including phosphorylation (Scroggins and Neckers, 2007) , ubiquitylation (Kundrat and Regan, 2010) , acetylation Yang et al., 2008) , and nitrosylation (Martinez-Ruiz et al., 2005; Retzlaff et al., 2009) .
In this study, we generated the protein interaction network for SMYD2, SMYD3, and SMYD5. Characterization of each SMYD protein network revealed that they associate with both unique and shared subsets of proteins. Mass spectrometry and biochemical data also revealed that SMYD2 methylates HSP90a on lysine residues located on its NBD and DD, respectively. In addition, we found that HSP90 methylation by SMYD2 is partially reversed by LSD1 and inhibited by the presence of the co-chaperone HOP, suggesting that it can be dynamically regulated in vivo. Overall, our data provide insights into novel regulatory networks for three members of the SMYD family of KMTs and evidence that HSP90a is a novel substrate for SMYD2.
Results

SMYD proteins have non-overlapping protein networks
As shown in Figure 1A , all human SMYD proteins include the SET and MYND domain. In addition, the highly homologous SMYD1, SMYD2 (data not shown), and SMYD3 share a TPR-like domain found on their C-termini ( Figure 1B) . Comparatively, SMYD4 has an additional region of 240 amino acids on its N-terminus while SMYD5 lacks any clear domain other than the SET and MYND domain, but has a C-terminal glutamate-rich extension.
To investigate whether the structural differences between SMYD2, SMYD3, and SMYD5 underlie the formation of alternative protein complexes, we have undertaken to establish the protein network specific for these SMYD proteins. Overall, 28, 33, and 9 proteins were found to bind with SMYD2, SMYD3, and SMYD5 (Supplementary Tables S1-3), respectively, and the interactions with each SMYD were further inspected. SMYD2 and SMYD3 share more interacting proteins (14 interactors) showing higher similarity than with SMYD5 (both 6 interactors) (Figure 2A) . Overall, SMYD-bound proteins can be divided into three main functional groups: chromatin remodeling and histone modification function such as CHD6, HP1BP3, TOP1, and JARID1B (Lutz et al., 2006; Scibetta et al., 2007; Kwon and Workman, 2008; Trievel and Shilatifard, 2009; Tuduri et al., 2009) ; gene expression regulation and DNA damage repair function such as DHX9, PARP1, RIF1, and XRCC6 (Bouchard et al., 2003; Schlegel et al., 2003; Collis et al., 2005; Wang et al., 2009) ; and chaperone and co-chaperone function (unique to SMYD2 and SMYD3) such as HSP90 (a and b), p23, p50, and HOP. Consistent with recent studies, we also found that SMYD2 associates with proteins involved in cell-cycle regulation, DNA damage response, and chaperone machinery (Brown et al., 2006; Abu-Farha et al., 2008) .
To further confirm the binding of HSP90 to SMYD2 and SMYD3, we performed reciprocal co-immunoprecipitation experiments in HEK293 cells. Consistent with our MS data, we detected a specific enrichment of HSP90a with SMYD2 and SMYD3 ( Figure 2B) . Similarly, reciprocal enrichment of HSP90-bound proteins revealed that both SMYD2 and SMYD3 co-eluted with the chaperone while we failed to detect an interaction between HSP90a and SMYD5. We then performed GST pull-down experiment to identify the region of HSP90 interacting with SMYD2. After co-incubating HSP90 domains with GST-SMYD2, proteins were applied onto glutathione Sepharose, washed extensively, and eluted with reduced glutathione. Notable binding was observed for full-length HSP90 and its DD (Supplementary Figure S1 ). However, similar to the binding reactions performed with the bacterial lysates containing GST alone, no enrichment of NBD or MD was detected. These results indicate that the NBD and MD of HSP90 are accessory to the binding of SMYD2, and likely SMYD3, to HSP90.
HSP90a is specifically methylated by SMYD2
Following the identification of the protein networks associating with different SMYD proteins, we surmised that specific interacting proteins could be genuine substrates for these enzymes. To examine this possibility, we probed the SMYD2-bound fraction with a pan methyl-lysine antibody and detected a prominent methylated protein migrating at 90 kDa. Methylation of this protein was dependent on SMYD2 methyltransferase activity as no signal could be detected with a catalytically inactive SMYD2-DGEE ( Figure 3A ) (Abu-Farha et al., 2008) . To confirm the methylation of HSP90a, we performed in vitro methyltransferase assays with recombinantly purified SMYD2 and HSP90a and observed that the chaperone is methylated by SMYD2 ( Figure 3B ), an activity specific to SMYD2 when compared with other SMYD proteins and known non-HKMTs (Supplementary Figure S2) .
Methylation of histone proteins by SET domain KMTs is maximal at alkaline pH (Del Rizzo and Trievel, 2011) , which likely reflects on the basic environment of the nucleus. Given that HSP90a is predominantly found in the cytosol, we asked if the methylation of HSP90a by SMYD2 would diverge from other known HKMTs. To determine the optimal pH for HSP90a methylation by SMYD2, we performed methyltransferase assays in conditions ranging from pH 6.0 to 10.0 ( Figure 3C ). Consistent with other HKMTs, pH profile analysis of histone H3 methylation by SMYD2 revealed a sharp maximum of activity at alkaline pH values (pH 9.0-10.0). However, methylation of HSP90a by SMYD2, either in the presence or absence of histone H3, peaked between pH 7.5 and 8.0 ( Figure 3C ). These results indicate that SMYD2 preferentially methylates HSP90a and histone H3 at neutral and alkaline pH values, respectively. In addition, these results highlight a hitherto unknown mechanism for SET domain KMTs that may control the type of substrate SMYD2 methylates depending on its cellular environment.
SMYD2 methylates two residues in two domains of HSP90a
After establishing that HSP90a is methylated by SMYD2, we sought to identify the methylation sites on HSP90a (Figure 4) . We first performed an in vitro methyltransferase assay with HSP90a constructs corresponding to the NBD, MD, and DD. As shown in Figure 4A , we found that SMYD2 strongly methylates the dimerization domain of HSP90. In addition, in the presence of histone H3, we detected a noticeable band corresponding to the NBD of HSP90a. These results suggest that at least two lysine residues on HSP90a are methylated by SMYD2.
Based on these results, we next sought to identify the lysine residues methylated by SMYD2. SMYD2-Flag was transiently expressed in HEK293 cells and SMYD2 complexes were purified using anti-Flag conjugated M2 agarose beads. The enriched HSP90a was detected by silver staining, trypsinized, and the peptides were analyzed by HPLC-ESI-MS/MS. Two major methyllysinecontaining peptides were identified corresponding to regions neighboring K209 and K615 residues ( Figure 4B and Supplementary Figure S3 ). To further confirm that these two amino acids were genuine SMYD2 methylation sites, we substituted K209 and K615 to arginine residues and homogeneously purified the full-length HSP90a mutants. As suggested by our MS/MS data, incubation of SMYD2 with HSP90 K615R mutant resulted in a severe loss of methylation. In addition, consistent with the stimulatory role of histone H3 on the SMYD2-mediated HSP90a K209 methylation, co-incubation of histone H3 with HSP90a K615R partially rescued the lost of methylation of HSP90a K615R mutant ( Figure 4C ). Given that K615 is the predominant methylation site on HSP90a, methylation reactions performed with the full-length HSP90a K209R mutant did not impact the overall level of methylation by SMYD2. However, reactions performed with HSP90a NBD K209R mutant, similar to the HSP90a DD K615R mutant and HSP90a K209R/K615R double mutant, fully abrogated the methylation by SMYD2 ( Figure 4D-F) . Overall, these results demonstrate that SMYD2 methylates two lysine residues on HSP90a. Considering that methylation of K209 requires the presence of histone H3 or alkaline pH values and K615 is more readily methylated at neutral pH, our observations also suggest that, although catalyzed by the same enzyme, alternative mechanisms will control the methylation of these two lysine residues. HSP90 methylation is modulated by its co-chaperones
After identifying K209 and K615 as genuine methylation sites, we sought to identify the regulatory mechanisms controlling the methylation of HSP90a by SMYD2. HSP90a is virtually always found in complex with co-chaperones and client proteins. For instance, the co-chaperone p50 associates with HSP90
′ s NBD and is necessary for the regulation of numerous kinases (Roe et al., 2004) . Upon binding to HSP90 MD, AHA1 increases HSP90 ATPase activity and stabilizes HSP90 N-terminal dimer (Lotz et al., 2003) . HOP recognizes HSP90 five C-terminal residues through its TPR domain and recruits HSP70 to the HSP90 'chaperone machinery' during certain chaperoning activities (Pratt and Toft, 2003) .
To determine the effects of these three canonical HSP90 co-chaperones, p50, AHA1, and HOP were homogeneously purified and increasing amount of each co-chaperone was incubated with HSP90 and methylated by SMYD2. As shown in Figure 5A , co-incubation of increasing amount of p50 and AHA1 did not result in a significant loss of methylation in all ratio assayed while the presence of HOP caused a drastic decrease in HSP90 methylation by SMYD2. Given that HOP mainly associates with HSP90 dimerization domain, the loss of methylation is consistent with our findings that this domain is the predominant site of methylation by SMYD2.
Methylation of HSP90a K615 can be reversed by LSD1
LSD1 is a flavin-dependent monoamine oxidase, which demethylates the methylated forms of p53 (Huang et al., 2007) and histone H3 (Shi et al., 2004) . As LSD1 is the major enzyme reported to demethylate non-histone proteins and is also known to demethylate the SMYD2-methylated p53, we asked whether LSD1 would demethylate HSP90. Pre-methylated [ 3 H]-HSP90a (Me-HSP90a) was incubated with increasing amount of LSD1 and either Me-HSP90a or Me-HSP90a-NBD and visualized by autoradiography. As shown in Figure 5B , we observed a noticeable decrease in the methylated form of full-length HSP90a, while the same reactions performed with the HSP90 NBD did not result in a significant lost of methylation, suggesting that the K615 methylation site is a substrate for LSD1. In addition, our findings support the idea that methylation of the NBD and DD of HSP90a depends on different mechanisms, albeit elicited by the same methyltransferase.
Discussion
Cancerous phenotypes associated with misregulated levels of SMYD proteins (Hamamoto et al., 2006; Hu et al., 2009; Komatsu et al., 2009 ) and their underlying roles in gene expression regulation (Hamamoto et al., 2004; Brown et al., 2006; Abu-Farha et al., 2008) were initially rationalized by their histone methyltransferase activity. Subsequently, their activities toward non-histone proteins were put in evidence, notably for SMYD2 and SMYD3 (Huang et al., 2006; Kunizaki et al., 2007; Komatsu et al., 2009; Yamamoto et al., 2011) . In an attempt to gain a global understanding of these functions, we determined their interaction network, along with their divergent family member, SMYD5.
The identification of SMYD2, SMYD3, and SMYD5 interaction networks suggests a set of similar roles for SMYD proteins involving chromatin modification, control of gene expression, and DNA damage response. This is in agreement with previous studies linking SMYD family members with cell-cycle progression and developmental processes (Gottlieb et al., 2002; Sims et al., 2002; Hamamoto et al., 2004; Brown et al., 2006; Tan et al., 2006; Abu-Farha et al., 2008; Thompson and Travers, 2008; Hu et al., 2009; Li et al., 2009a) . Among the interactors we observed as shared between SMYD2 and SMYD3 include the DNA sliding clamp proliferating cell nuclear antigen together with its replication factors (RFC1 and RFC3) and mini-chromosome maintenance proteins (MCM3 and MCM4). Interestingly, these proteins are known to interact with DNA polymerase d during DNA damage response (Coue et al., 1996; Cai et al., 1997; Uhlmann et al., 1997; Johnson and O'Donnell, 2005; Li et al., 2006 Li et al., , 2009b Overmeer et al., 2010) . It is thus possible that both SMYD proteins act in DNA polymerase d-dependent processes, possibly by methylating histone or non-histone proteins. In addition, the interactors shared between SMYD2, SMYD3, and SMYD5 (NPM1, TOP1, GNL3, RUVBL2) are associated with DNA repair and chromatin maintenance during cell cycle, notably through regulation of p53. This observation further links SMYD proteins with the tumor suppressor, as SMYD2 was already shown to inhibit p53 apoptotic function (Huang et al., 2006) .
The observation that the interaction with the HSP90 chaperone machinery group is restricted to SMYD2 and SMYD3 in our study suggests that it might be a feature of TPR-containing SMYD proteins. This hypothesis is supported by our pull-down assay, showing that SMYD2 interacts physically and specifically with the C-terminal dimerization domain of HSP90 (Supplementary Figure S1) , a mechanism likely applicable to SMYD1, SMYD3, and SMYD4. It is interesting to note that a TPR-like domain is a widespread feature among the SMYD family in higher eukaryotes and numerous SMYD proteins are known to interact with HSP90 (Hamamoto et al., 2004; Tan et al., 2006; Abu-Farha et al., 2008) . As phosphorylation and ubiquitylation signaling is already known to be regulated by HSP90 through its interaction with kinases (Scroggins and Neckers, 2007) and E3 ubiquitin ligases (Hatakeyama et al., 2004) , further investigation will determine the influence of HSP90 on the cell methylome. Our results illustrate that SMYD2 is unique among the SMYD proteins in its capacity to methylate HSP90a. This also represents the first direct report of lysine methylation of the chaperone, which can be added to a growing list of HSP90 PTMs along acetylation, phosphorylation, nitrosylation, and ubiquitylation. Our results show that SMYD2 methylates two residues in two distinct regions of the protein, each under specific conditions in vitro. While K615 represents the major methylation site in HSP90 DD, its NBD is methylated at residue K209 at alkaline pH and in the presence of histone H3.
Alignment of SMYD2 methylation sites reveals that both K209 and K615 neighboring sequences show only weak sequence homology with previously identified SMYD2 methylation sites (Supplementary Figure S4) . Moreover, crystal structure of HSP90 (PDB ID: 2CG9) shows that both methylation sites on HSP90 are located at the edge of a-helices ( Figure 4G ). These observations are in clear contrast with other SMYD2 methylation sites found on histone H3, p53, and pRb which are predominantly found in loops, raising the possibility that SMYD2 might recognize its substrates employing alternative binding modes.
HSP90 methylation by SMYD2 does not modulate its ATPase activity (Supplementary Figure S5 ) but appears to be controlled by different factors. Methylation of K209 is dependent on the presence of histone H3. This infers that a tripartite complex between histone H3, HSP90, and SMYD2 elicits this additional activity. On the other hand, formation of the complex between HOP and HSP90, contrasting with other co-chaperones assayed, impairs the methylation of K615 by SMYD2, suggesting that the early phases of the HSP90 chaperoning cycle, as HOP mediates the recruitment of HSP70 (Chen and Smith, 1998; Pratt and Toft, 2003) , would be impervious to lysine methylation. Other complexes might affect the installment of lysine methylation on HSP90. For example, K209 of human HSP90a is equivalent to R196 in HSP82 (homolog of HSP90 in budding yeast). Crystal structure of the full-length HSP82 (PDB ID: 2CG9) reveals that R196 is located in a-helix 8, a hinge region between HSP90 NBD and MD (Supplementary Figure S6) . Analysis of this region of HSP90 shows that K209 might play a role in the stabilization of the closed conformation of the protein by engaging in polar contacts with the MD. Alternatively, given that R196 interacts with p50 (PDB ID: 1US7), methylation of the structurally equivalent K209 might influence the formation of the HSP90-p50 complex. On the other hand, the same residue does not participate in the binding of the co-chaperone p23. Consequently, methylation of K209 could affect specific subsets of HSP90 co-chaperones and therefore client proteins, while leaving intact other HSP90 complexes.
Our findings that K209 and K615 are regulated, in vitro, by diverging mechanisms may be indicative of different roles in the cell. In fact, we have observed that the activity of SMYD2, at more alkaline pH, directs its activity toward the methylation of HSP90 K209 and histone H3 while pH closer to the neutral point are conducive for HSP90 K615 methylation. As a positively charged environment and the presence of histone proteins are hallmarks of the nuclear environment, it is likely that K209 will be methylated in the nucleus. In addition, our findings that LSD1, a nuclear lysine demethylase (Shi et al., 2004) , specifically demethylates K615 raise the possibility that compartment-dependent subsets of complexes would direct the methylation of specific lysine residues on HSP90 by SMYD2. Interestingly, previous reports have shown that the cellular compartmentalization of various SMYD proteins changed during cell-cycle progression (Gottlieb et al., 2002; Hamamoto et al., 2004; Thompson and Travers, 2008) and that such shuttling mechanism could modulate the activity of members of the SMYD family of KMTs Yamamoto et al., 2011) .
Cross-talk between PTMs is a key mechanism controlling the addition or removal of other marks on proteins. As observed for RelA (Yang et al., 2010; Levy et al., 2011) and DNMT1 (Esteve et al., 2011) , our data also point to an alternative model in which other PTMs affect the methylation of HSP90, or inversely, HSP90 methylation modulates other PTMs. HSP90 K615 was identified in a previous study to be ubiquitylated by the ubiquitin ligase CHIP. Based on our results, it is expected that both enzymes would compete for this residue. Accordingly, it is tempting to speculate that methylation of K615 would prevent HSP90a degradation and extend the half-life of HSP90 complexes, a hypothesis recently supported by Pang et al. (2010) .
Materials and methods
Cell culture and mammalian expression of SMYD-Flag constructs and Flag-immunoprecipitation experiments
HEK293T cells were grown and transfected as previously described (Abu-Farha et al., 2008) . Transfections and immunoprecipitation experiments (either using agarose beads or Dynabeads) are detailed in the Supplementary material.
MS analysis
MS experiments were performed and analyzed as previously described (Abu-Farha et al., 2008) with minor modifications (see Supplementary material for details). Protein purification, pull-down, and in vitro enzymatic assays Protein purification, pull-down experiments, as well as methyltransferase and demethylase assays were performed as described in Supplementary material.
Supplementary material
Supplementary material is available at Journal of Molecular Cell Biology online.
